Noblegen Inc.

Based in Canada, Noblegen Inc. is a biotechnology firm focused on the development of innovative microbial solutions for sustainable food and agriculture applications. Noblegen Inc. specializes in creating sustainable microbial products that enhance food and agricultural processes.

Founded in 2013 in Peterborough, Canada, the company has been involved in five significant deals, with the most recent funding round, Series B, closing in July 2023 for CAD 25. 000 mn, led by Cleantech Practice and James Richardson & Sons. In July 2023, the company was acquired by SolarBiotech, Inc. and will now operate under the name Solar Biotech Canada.

Noblegen Inc. offers a distinctive range of microbial solutions designed to enhance food quality and agricultural productivity. Their products are characterized by their natural ingredients aimed at improving sustainability in various applications, including food preservation and crop management. The company primarily serves the North American market, focusing on industries that are increasingly prioritizing environmentally friendly alternatives.

Revenue generation for Noblegen Inc. stems from the sale of its microbial products targeted at both the food and agricultural sectors. The business model is structured around direct sales to manufacturers and growers, facilitating access to sustainable solutions that cater to a market increasingly focused on eco-friendly practices. Following its acquisition by SolarBiotech, Inc.

, Noblegen Inc. plans to expand its facility and increase staffing to support enhanced production capabilities. The company aims to introduce new microbial products tailored to meet the growing demand for sustainable practices in agriculture and food production. With the recent funding from the Series B round, Noblegen will invest in research and development to innovate its product offerings and explore new market opportunities throughout North America.